COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 188 filers reported holding COHERUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $52 | -46.4% | 12,062 | -1.3% | 0.00% | -25.0% |
Q1 2023 | $97 | 0.0% | 12,223 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $97 | -99.9% | 12,223 | +4.8% | 0.00% | -20.0% |
Q3 2022 | $112,000 | +13.1% | 11,665 | -14.3% | 0.01% | +25.0% |
Q2 2022 | $99,000 | -35.3% | 13,612 | +14.6% | 0.00% | -20.0% |
Q1 2022 | $153,000 | -8.9% | 11,874 | +13.3% | 0.01% | 0.0% |
Q3 2021 | $168,000 | – | 10,477 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |